Poorer functionality is related to better quality of life response following the use of biological drugs: 6-month outcomes in a prospective cohort from the Public Health System (Sistema Único de Saúde), Minas Gerais, Brazil

References

• Gibofsky A . Overview of epidemiology, pathophysiology, and diagnosis of rheumatoid arthritis. Am J Manag Care 2012;18(13):S295-302
   PubMedGoogle Scholar
• Brodszky V , Péntek M , Bálint PV , et al. Comparison of the Psoriatic Arthritis Quality of Life (PsAQoL) questionnaire, the functional status (HAQ) and utility (EQ-5D) measures in psoriatic arthritis: results from a cross-sectional survey. Scand J Rheumatol 2010;39:303-9
   PubMed Web of Science ®Google Scholar
• Dean LE , Jones GT , MacDonald AG , et al. Global prevalence of ankylosing spondylitis. Rheumatology 2014;53:650-7
   PubMed Web of Science ®Google Scholar
• Senna ER , De Barros AL , Silva EO , et al. Prevalence of rheumatic diseases in Brazil: a study using the COPCORD approach. J Rheumatol 2004;31(3):594-7
   PubMed Web of Science ®Google Scholar
• BRASIL . Ministério da Saúde. Secretaria de Atenção à Saúde. Portaria n. 710, de 17 de junho de 2013. Aprova o Protocolo Clínico e Diretrizes Terapêuticas da Artrite Reumatoide [Ministry of Health. Health Care Secretary. Ruling no. 710, from June 17 2013. Approval of Clinical Protocols and Therapeutic Guidelines for Rheumatoid Arthritis]. Brasil. 2013.
   Google Scholar
• Gordeev VS , Maksymowych WP , Evers SM , et al. Role of contextual factors in health-related quality of life in ankylosing spondylitis. Ann Rheum Dis 2010;69:108-12
   PubMed Web of Science ®Google Scholar
• Alava M H , Wailoo A , Wolfe F , Michaud K . The relationship between EQ-5D, HAQ and pain in patients with rheumatoid arthritis. Rheumatology 2013;52:944-50
   PubMed Web of Science ®Google Scholar
• Ariza-Ariza R , Hernández-Cruz B , López-Antequera G , Navarro-Sarabia F . Variables related to utility in patients with ankylosing spondylitis. Clin Rheumatol 2009;28:207-11
   PubMed Web of Science ®Google Scholar
• Gaujoux-viala C , Fautrel B , Guillemin F , et al. Who are the patients with early arthritis with worse than death scores on the EQ-5D? Results from the ESPOIR cohort. Rheumatology 2013;52:832-8
   PubMed Web of Science ®Google Scholar
• Da Rocha Castelar Pinheiro G , Khandker RK , Sato R , et al. Impact of rheumatoid arthritis on quality of life, work productivity and resource utilisation: an observational, cross-sectional study in Brazil. Clin Exp Rheumatol 2013;31(3):334-40
   PubMed Web of Science ®Google Scholar
• Arnett FC , Edworthy SM , Bloch DA , et al. The American Rheumatism Association 1987 revised criteria for classification of rheumatoid arthritis. Arthritis Rheum 1988;31(3):315-24
   PubMed Web of Science ®Google Scholar
• Van der linden S , Valkenburg HA , Cats A . Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum 1984;27:361-8
   PubMed Web of Science ®Google Scholar
• Taylor W , Gladman D , Helliwell P , et al. Classification for psoriatic arthritis: development of new criteria from a large international study. Arthritis Rheum 2006;54(8):361-8
   Web of Science ®Google Scholar
• BRASIL . Ministério da Saúde. PORTARIA Nº 1.554, DE 30 DE JULHO DE 2013. Dispõe sobre as regras de financiamento e execução do Componente Especializado da Assistência Farmacêutica no âmbito do Sistema Único de Saúde (SUS) [Ministry of Health. Ruling no. 1,554, from July 30 2013. Establishment of the rules for funding and implementation of the Specialized Component of Pharmaceutical Care within the Public Health System]. 2013
   Google Scholar
• Garret S , Jenkinson T , Kennedy LG , et al. A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index. J Rheumatol 1994;21:2286-91
   PubMed Web of Science ®Google Scholar
• Aletaha D , Smolen J . The Simplified Disease Activity Index (SDAI) and Clinical Disease Activity Index (CDAI): a review of their usefulness and validity in rheumatoid arthritis. Clin Exp Rheumatol 2005;23(5 Suppl 39):100-8
   PubMed Web of Science ®Google Scholar
• Bruce B , Fries JF . The Stanford Health Assessment Questionnaire: a review of its history, issues, progress, and documentation. J Rheumatol 2003;30(1):100-8
   Web of Science ®Google Scholar
• Ferraz MB , Oliveira LM , Araujo PM , et al. Crosscultural reliability of the physical ability dimension of the Health Assessment Questionnaire. J Rheumatol 1990;17(6):813-17
   PubMed Web of Science ®Google Scholar
• EuroQol Group . EQ-5D a measure of health-related quality of life developed by the EuroQol group: user guide. 7th edition. EuroQol Group; Rotterdam, The Netherlands: 2000
   Google Scholar
• Andrade MV , Noronha K , Maia AC , et al. Sistemas de valores do instrument EQ-5D de mensuração da qualidade de vida relacionada à saúde: uma análise para o estado de minas Gerais [Value system of the EQ-5D instrument for the measurement of health-related quality of life: an analysis for the state of Minas Gerais]. Grupo de Estudos em Economia da Saúde e Criminalidade, Centro de Desenvolvimento e Planejamento Regional – CEDEPLAR, Universidade Federal de Minas Gerais-UFMG. 2012.
   Google Scholar
• Karlsson JA , Nilsson JA , Neovius M , et al. National EQ-5D tariffs and quality-adjusted life-year estimation: comparison of UK, US and Danish utilities in south Swedish rheumatoid arthritis patients. Ann Rheum Dis 2011;70:2163-6
   PubMed Web of Science ®Google Scholar
• Cho SK , Kim D , Jun JB , et al. Factors influencing quality of life (QOL) for Korean patients with rheumatoid arthritis (RA). Rheumatol Int 2013;33(1):93-102
   PubMed Web of Science ®Google Scholar
• Cavalcanti FS . Management of rheumatoid diseases: the Brazilian perspective. Rheumatology 2010;49:2231-2
   PubMed Web of Science ®Google Scholar
• da Mota LM , Dos Santos Neto LL , Oliveira AC , et al. Baseline HAQ and SF-36 questionnaire scores cannot predict clinical remission, radiographic progression or the need for biological therapy in a three-year prospective study of a Brazilian early rheumatoid arthritis cohort. Rheumatol Int 2012;32:3937-43
   PubMed Web of Science ®Google Scholar
• Ide MR , Gonzales-Gay MA , Yano KC , et al. Functional capacity in rheumatoid arthritis patients: comparison between Spanish and Brazilian sample. Rheumatol Int 2011;31:221-6
   PubMed Web of Science ®Google Scholar
• De Oliveira Costa J , Almeida AM , Guerra Junior AA , et al. Treatment of rheumatoid arthritis in the Brazilian Unified National Health System: expenditures on infliximab compared to synthetic disease-modifying anti-rheumatic drugs, 2003-2006. Cad Saude Publica 2014;30(2):283-95
   PubMed Web of Science ®Google Scholar
• Titton DC , Silveira IG , Louzada-Junior P , et al. Registro Brasileiro de Biológicos: processo de implementação e resultados preliminares do BiobadaBrasil. Rev Bras Reumatol 2011;51(2):145-60
   Google Scholar
• Wiens A , Grochocki C , Pontarolli DR , et al. Profile of users of anticytokines offered by the health care system in the state of Paraná for the treatment of rheumatoid arthritis. Rev Bras Reumatol 2012;52(2):203-13
   Web of Science ®Google Scholar
• Carreño A , Fernández I , Badia X , et al. Using HAQ-DI to estimate HUI-3 and EQ-5D utility values for patients with rheumatoid arthritis in Spain. Value Health 2011;14:192-200
   PubMed Web of Science ®Google Scholar
• Kontodimopoulos N , Bozios P , Yfantopoulos J , et al. Longitudinal predictive ability of mapping models: examining post-intervention EQ-5D utilities derived from baseline MHAQ data in rheumatoid arthritis patients. Eur J Health Econ 2013;14:307-14
   PubMed Web of Science ®Google Scholar
• Sullivan PW , Lawrence WF , Ghushchyan V . A national catalog of preference-based scores for chronic conditions in the United States. Med Care 2005;43:736-49
   PubMed Web of Science ®Google Scholar
• Walters SJ , Brazier JE . Comparison of the minimally important difference for two health state utility measures: EQ-5Dand SF-6D. Qual Life Res 2005;14:1523-32
   PubMed Web of Science ®Google Scholar
• Gülfe A , Kristensen LE , Saxne T , et al. Rapid and sustained health utility gain in anti-tumour necrosis factor-treated inflammatory arthritis: observational data during 7 years in southern Sweden. Ann Rheum Dis 2010;69:352-7
   PubMed Web of Science ®Google Scholar
• Pinto EB , Maso I , Vilela RN . Validation of the EuroQol quality of life questionnaire on stroke victims. Arq Neuropsiquiatr 2011;69(2-B):320-3
   PubMedGoogle Scholar
• Braun J , McHugh N , Singh A , et al. Update of the ASAS/EULAR recommendations for the management of ankylosing spondylitis. Ann Rheum Dis 2010;70:896-904
   Web of Science ®Google Scholar
• Soriano ER , Mc Hugh NJ . Therapies for peripheral joint disease in psoriatic arthritis. A systematic review. J Rheumatol 2006;33:1422-30
   PubMed Web of Science ®Google Scholar
• Griffiths CEM . Therapy for psoriatic arthritis: sometimes a conflict of interest. Br J Rheumatol 1997;36:409-12
   PubMedGoogle Scholar
• Pipitone N , Kingsley GH , Manzo A , et al. Current concepts and new developments in the treatment of psoriatic arthritis. Rheumatology (Oxford) 2003;42:1138-48
   PubMed Web of Science ®Google Scholar
• Osvaldo Cruz Foundation . RADIS Magazine number 145 – October 2014, page 5. Available from: www.ensp.fiocruz.br/radis
   Google Scholar
• Helfenstein M Jr , Halpern AS , Bertolo MB . Investigation on Brazilian clinical practices in rheumatoid arthritis: the Brazilian rheumatoid arthritis clinical practices investigation – BRACTICE. J Clin Rheumatol 2011;17(4 Suppl 1):S1-S10
   PubMed Web of Science ®Google Scholar